Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Pomdoctor Limited due to allegations of securities law violations, with a deadline for investors to seek lead plaintiff status by April 13, 2026 [1] Group 1: Allegations Against Pomdoctor - The complaint alleges that Pomdoctor and its executives made false or misleading statements and failed to disclose critical information, including involvement in a fraudulent stock promotion scheme [1] - It is claimed that insiders used offshore or nominee accounts to facilitate coordinated share dumping during a price inflation campaign [1] - Pomdoctor's public statements and risk disclosures reportedly omitted any mention of false rumors and artificial trading activity that influenced the stock price [1] - As a result of these actions, the positive statements made by the defendants regarding the company's business and prospects were materially misleading [1] Group 2: Stock Price Decline - Pomdoctor's share price experienced a significant decline from approximately $0.50 per share on December 10, 2025, to about $0.38 per share on December 11, 2025, marking a drop of roughly $0.12 per share or approximately 24% in a single trading session [1] - This decline followed increased volatility and selling pressure amid broader investor concerns regarding Pomdoctor's financial performance and valuation [1] Group 3: Legal Proceedings - The court-appointed lead plaintiff will be the investor with the largest financial interest in the relief sought, who is also typical of class members [1] - Any member of the putative class can move the court to serve as lead plaintiff or choose to remain an absent class member without affecting their ability to share in any recovery [1] - Faruqi & Faruqi, LLP encourages anyone with information regarding Pomdoctor's conduct to come forward, including whistleblowers and former employees [1]
POM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Pomdoctor Investors of Securities Class Action Deadline on April 13, 2026